Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Shares Outstanding (Weighted Average) (2019 - 2025)

Pulmonx (LUNG) has disclosed Shares Outstanding (Weighted Average) for 7 consecutive years, with $40.4 million as the latest value for Q3 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 3.83% to $40.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $40.4 million through Sep 2025, up 3.83% year-over-year, with the annual reading at $39.1 million for FY2024, 2.93% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $40.4 million at Pulmonx, roughly flat from $40.4 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $40.4 million in Q3 2025, with the low at $35.4 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $37.9 million, with a median of $37.8 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) skyrocketed 1762.25% in 2021, then rose 1.46% in 2023.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $36.4 million in 2021, then rose by 1.9% to $37.1 million in 2022, then rose by 2.43% to $38.0 million in 2023, then increased by 2.93% to $39.1 million in 2024, then grew by 3.41% to $40.4 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $40.4 million, $40.4 million, and $40.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.